Skip to the card

2026-10-16 issue

Observed arrival · 2026-10-16

Versil’s injectable trauma-foam project

versiltech.com Visit website
Editorial interest 78/100 Selection signal · not a rating of the site

A University of Central Florida spinout is developing an injectable, self-expanding foam intended to seal deep wounds that gauze cannot readily compress.

Landing page captured for the 2026-10-16 issue.
For
Trauma-care responders and potential research partners
Worth noticing
The site marks the device investigational and not yet FDA-cleared, and labels its comparison table representative rather than definitive.

Field notes

The described mechanism combines cavity-filling expansion with outward pressure and clotting action. The page names two UCF co-founders, including the core technology’s inventor, and provides a comparison table while qualifying it as representative. Its explicit investigational-device and FDA-clearance caveat is important context for the performance claims.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
●ProPolished or operationally mature
◎NicheUnusually specific use

One card from the complete issue

Sixty Names in a Minute

343,727 arrived 1,000 judged 985 catalogued Enter the complete issue
versiltech.com

Landing page observed 2026-10-16. The live site may have changed.